Gentina
Lille, 59000, France
NCT Number: NCT04894175
The objective of the study is to define an optimal threshold of the SEMSA-15 scale for obstructive sleep apnea (OSA) perception in patients with OSA to predict 3-month and 1-year continuous positive airway pressure adherence.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Lille, 59000, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3-month
To define an optimal threshold for the Self-efficacy Measure for Sleep Apnea (SEMSA-15) scale to predict 3-month CPAP adherence
Time frame: 1-year
To define an optimal threshold for the Self-efficacy Measure for Sleep Apnea (SEMSA-15) scale to predict 1-year CPAP adherence
Time frame: 3-month and 1-year
Use Self-efficacy Measure for Sleep Apnea (SEMSA-15) scale and socio-economics parameter from patients to improve CPAP adherence prediction
Time frame: 3-month and 1-year
Use of Health Litteracy Questionnaire HLQ
Time frame: 3-month and 1-year
Use of Deprivation in Primary Care (DIPCARE-Q) questionnaire
Time frame: 3-month and 1-year
Use of simplified Short-Form (SF-36) questionnaire for quality of life (SF-12 questionnaire)
Time frame: 3-month and 1-year
CPAP Adherence
Time frame: 3-month and 1-year
CPAP adherence trajectories
Time frame: 1-year
Quality of life
Time frame: At inclusion
Clinical and socio-demographic phenotype at CPAP initiation
Thibaut Gentina
Industry
Association Between Treatment Perception and Treatment Adherence in Obstructive Sleep Apnea Patients Treated by Continuous Positive Airway Pressure (SEMSAS Study)
Acronym: SEMSAS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03043716
Apnea, Central Sleep Apnea
Blaubeuren Abbey, Baden-Wurttemberg, Germany
View Trial DetailsNCT05650710
Apnea, Dyssomnias
Nashville, Tennessee, United States
View Trial DetailsNCT06039865
Apnea, Behavior
North Hills, California, United States
View Trial DetailsNCT05067088
Apnea, Dyssomnias
North Haven, Connecticut, United States
View Trial Details